XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th Profit Margin

As of the most recent data (March 2026), XOMAO shows a profit margin of 64.89%. That compares with -7.82% in the prior-year period — up 929.3% year over year. That is above the Healthcare sector average of 14.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, XOMAO's profit margin is now 64.89% (was -7.82%) — a 929.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th is outperforming or lagging.

The Healthcare sector average profit margin is about 14.34%. XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th is at 64.89%, which is higher that average. That is roughly 352.4% above the sector mean. Use the comparison chart on this page to see how XOMAO stacks up against individual peers as well.

That compares with -7.82% in the prior-year period — up 929.3% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 64.89%) with ownership activity and broader fundamentals.